These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 27488337

  • 1. Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma.
    Kader I, Leavers B, Shashinder S, Wylie B, Chi KK, Sundaresan P.
    J Laryngol Otol; 2016 Jul; 130 Suppl 4():S45-9. PubMed ID: 27488337
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H, Yano T, Yoda Y, Oono Y, Ikematsu H, Hayashi R, Ohtsu A, Kaneko K.
    World J Gastroenterol; 2017 Feb 14; 23(6):1051-1058. PubMed ID: 28246479
    [Abstract] [Full Text] [Related]

  • 3. Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
    Goyal P, Hsu JM, Kellman RM.
    J Otolaryngol Head Neck Surg; 2008 Oct 14; 37(5):694-9. PubMed ID: 19128678
    [Abstract] [Full Text] [Related]

  • 4. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
    Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ.
    Head Neck; 2010 Mar 14; 32(3):319-25. PubMed ID: 19626642
    [Abstract] [Full Text] [Related]

  • 5. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
    Qualliotine JR, Mydlarz WK, Chan JY, Zhou X, Wang H, Agrawal N.
    J Laryngol Otol; 2015 Dec 14; 129(12):1213-9. PubMed ID: 26490394
    [Abstract] [Full Text] [Related]

  • 6. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
    Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF.
    Eur J Nucl Med Mol Imaging; 2009 Jun 14; 36(6):919-27. PubMed ID: 19205699
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
    Paleri V, Zammit-Maempel I.
    J Clin Oncol; 2010 Oct 01; 28(28):e515. PubMed ID: 20606098
    [No Abstract] [Full Text] [Related]

  • 8. The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
    Prowse SJ, Shaw R, Ganeshan D, Prowse PM, Hanlon R, Lewis-Jones H, Wieshmann H.
    J Laryngol Otol; 2013 Aug 01; 127(8):780-7. PubMed ID: 23919968
    [Abstract] [Full Text] [Related]

  • 9. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
    Hanamoto A, Takenaka Y, Shimosegawa E, Ymamamoto Y, Yoshii T, Nakahara S, Hatazawa J, Inohara H.
    Ann Nucl Med; 2013 Dec 01; 27(10):880-5. PubMed ID: 23979967
    [Abstract] [Full Text] [Related]

  • 10. [18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality.
    de Souza JA, Cohen EE.
    J Clin Oncol; 2010 Oct 01; 28(28):e516; author reply e517. PubMed ID: 20606097
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive.
    Li L, Hamilton L, Montgomery J, Stewart M.
    J Laryngol Otol; 2020 May 01; 134(5):460-462. PubMed ID: 32308160
    [Abstract] [Full Text] [Related]

  • 13. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A.
    Clin Otolaryngol; 2012 Jun 01; 37(3):197-206. PubMed ID: 22520870
    [Abstract] [Full Text] [Related]

  • 14. [Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
    Rivière D, Morvan JB, Fakhry N, Vatin L, Cathelinaud O, Bousquet F, Giovanni A, Verdalle P.
    Rev Laryngol Otol Rhinol (Bord); 2014 Jun 01; 135(3):127-33. PubMed ID: 26521355
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
    Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Grégoire V.
    J Clin Oncol; 2010 Mar 01; 28(7):1190-5. PubMed ID: 20124179
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of positron emission tomography scanning in metastatic head and neck cutaneous squamous cell cancer: does it add to patient management?
    Supriya M, Suat-Chin N, Sizeland A.
    Am J Otolaryngol; 2014 Mar 01; 35(3):347-52. PubMed ID: 24503246
    [Abstract] [Full Text] [Related]

  • 19. FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer.
    Osman MM, Altinyay ME, Abdelmalik AG, Brickman TM, Varvares MA, Nguyen NC.
    Clin Nucl Med; 2011 Jun 01; 36(6):496-7. PubMed ID: 21552038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.